Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-04-04Clinical Trial Update: Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel
A clinical trial investigating biomarkers related to muscle and joint pain in patients with solid tumors receiving paclitaxel has been termi…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies [Phase 1]
Phase 1 safety and pharmacology study of SNX-5422 in subjects with refractory solid tumor malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma [Phase 1]
The update covers a Phase 1 study of ACE-041 in patients with advanced solid tumors and relapsed/refractory multiple myeloma. The trial stat…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment [Phase 1]
A Phase 1 study evaluated the combination of Velcade (bortezomib) and temozolomide in patients with brain tumors or other solid tumors that …
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Bevacizumab and Bortezomib in Patients With Advanced Malignancy [Phase 1]
This Phase 1 trial evaluated the combination of Bevacizumab and Bortezomib in patients with advanced malignancies, including lymphoma, multi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: STAT3 Inhibitor for Solid Tumors [Phase 1]
Phase 1 clinical trial of a STAT3 inhibitor in patients with advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 clinical trial evaluating phenylbutyrate in patients with refractory solid tumors or lymphoma, conducted by the National Cancer Inst…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma [Phase 1]
Phase 1 clinical trial evaluating irinotecan in combination with cyclosporine and phenobarbital in adults with solid tumors or lymphoma; the…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function [Phase 1]
A completed Phase 1 trial assessed temsirolimus in patients with metastatic solid tumors or lymphoma who have varying levels of liver functi…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study of 2-methoxyestradiol in patients with refractory or stage III multiple myeloma and other advanced solid tumors has complete…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma [Phase 1]
A completed Phase 1 study evaluating arsenic trioxide with pamidronate in patients with advanced solid tumors or refractory multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: PDM08 Clinical Trial in Advanced Solid Tumors [Phase 1]
Phase 1 trial PDM08 in advanced malignant solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma [Phase 1]
A Phase 1 trial of LBH589 (panobinostat) in adults with advanced solid tumors or cutaneous T-cell lymphoma has completed.
-
CLINICAL_TRIALS withdrawal · 2012-11-21Clinical Trial Update: Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma [Phase 1]
Phase 1 trial of imetelstat in children with refractory or recurrent solid tumors or lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors [Phase 1]
The Phase 1 dose-finding study of CP-870,893 in combination with paclitaxel and carboplatin for patients with metastatic solid tumors has co…
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor [Phase 1]
Phase 1 trial evaluating valproic acid-based two-agent oral regimens in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment [Phase 1]
Phase 1 extension study of ALN-VSP02 in cancer patients who responded to ALN-VSP02 treatment has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors. [Phase 1]
Abbott terminated a Phase 1 pharmacokinetic study of Linifanib (ABT-869) in male patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours [Phase 2]
A Phase 2 trial evaluating Cediranib (AZD2171) for advanced solid tumors, also examining hypertension management; the study is completed and…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Update on a Phase 1 pharmacokinetic study evaluating two linifanib formulations and the effect of food on linifanib in patients with solid t…
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating romidepsin in combination with gemcitabine in pancreatic and other advanced solid tumors has completed with results…
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma [Phase 1, Phase 2]
A Phase 1/2 study evaluated the combination of bortezomib and temozolomide in adults with advanced refractory solid tumors or melanoma; the …
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1/1b dose-escalation study of BSI-201 as a single agent and in combination with Irinotecan in advanced solid tumors; the trial has com…
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: TTP607 in Refractory Solid Malignancies [Phase 1]
Phase 1 trial of TTP607 for advanced cancers and lymphoma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies [Phase 1]
Phase 1 study of RTA 402 (bardoxolone methyl) in advanced solid tumors and lymphoid malignancies has completed.